Meyka Pro banner
Femasys Inc.

Femasys Inc. Fundamental Analysis (NASDAQ: FEMY)

FEMYNASDAQ
HealthcareMedical - Instruments & Supplies
$2.71
$0.51(23.41%)
U.S. Market is Open · 15:50

Femasys Inc. Fundamental Analysis (NASDAQ: FEMY)

Femasys Inc. (NASDAQ: FEMY) shows moderate financial fundamentals with a PE ratio of -0.57, profit margin of -5.34%, and ROE of -2.26%. The company generates $0.0B in annual revenue with strong year-over-year growth of 40.77%.

Key Strengths

Cash Position16.47%
PEG Ratio-0.00
Current Ratio2.14

Areas of Concern

ROE-2.26%
Operating Margin-7.64%
We analyze FEMY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -596.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-596.7/100

We analyze FEMY's fundamental strength across five key dimensions:

Efficiency Score

Weak

FEMY struggles to generate sufficient returns from assets.

ROA > 10%
-99.97%

Valuation Score

Excellent

FEMY trades at attractive valuation levels.

PE < 25
-0.57
PEG Ratio < 2
-0.00

Growth Score

Excellent

FEMY delivers strong and consistent growth momentum.

Revenue Growth > 5%
40.77%
EPS Growth > 10%
44.05%

Financial Health Score

Moderate

FEMY shows balanced financial health with some risks.

Debt/Equity < 1
1.19
Current Ratio > 1
2.14

Profitability Score

Weak

FEMY struggles to sustain strong margins.

ROE > 15%
-225.98%
Net Margin ≥ 15%
-5.34%
Positive Free Cash Flow
No

Key Financial Metrics

Is FEMY Expensive or Cheap?

P/E Ratio

FEMY trades at -0.57 times earnings. This suggests potential undervaluation.

-0.57

PEG Ratio

When adjusting for growth, FEMY's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Femasys Inc. at 2.18 times its book value. This may indicate undervaluation.

2.18

EV/EBITDA

Enterprise value stands at -0.47 times EBITDA. This is generally considered low.

-0.47

How Well Does FEMY Make Money?

Net Profit Margin

For every $100 in sales, Femasys Inc. keeps $-5.34 as profit after all expenses.

-5.34%

Operating Margin

Core operations generate -7.64 in profit for every $100 in revenue, before interest and taxes.

-7.64%

ROE

Management delivers $-2.26 in profit for every $100 of shareholder equity.

-2.26%

ROA

Femasys Inc. generates $-99.97 in profit for every $100 in assets, demonstrating efficient asset deployment.

-99.97%

Following the Money - Real Cash Generation

Operating Cash Flow

Femasys Inc. generates limited operating cash flow of $-15.88M, signaling weaker underlying cash strength.

$-15.88M

Free Cash Flow

Femasys Inc. generates weak or negative free cash flow of $-16.30M, restricting financial flexibility.

$-16.30M

FCF Per Share

Each share generates $-5.40 in free cash annually.

$-5.40

FCF Yield

FEMY converts -2.23% of its market value into free cash.

-2.23%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.57

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.18

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.44

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.19

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.14

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.26

vs 25 benchmark

ROA

Return on assets percentage

-1.00

vs 25 benchmark

ROCE

Return on capital employed

-2.09

vs 25 benchmark

How FEMY Stacks Against Its Sector Peers

MetricFEMY ValueSector AveragePerformance
P/E Ratio-0.5731.70 Better (Cheaper)
ROE-225.98%448.00% Weak
Net Margin-534.27%22837.00% Weak
Debt/Equity1.190.54 Weak (High Leverage)
Current Ratio2.145.63 Strong Liquidity
ROA-99.97%-49.00% (disorted) Weak

FEMY outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Femasys Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-34.29%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

19.89%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-12.68%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ